Fondazione Gianni Benzi is pleased to publish the results of the study performed by Dr. Barbara Frigeni entitled ‘THE NEUROPHYSIOLOGICAL STUDIES OF THE SURAL NERVE BACK AS EARLY MARKER OF DIABETIC NEUROPATHY’ – Clinic of Neurology, Department of Neuroscience and Biomedical Technology, San Gerardo Hospital in Monza – University Bicocca of Milan.

This study was supported  by a grant for research ‘Neurotoxicity of anticancer drugs’, banned for the year 2010 by the Foundation with the aim of supporting the biological and pharmacological research for the ethical and safe use of the medicines.